Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LUZU 1% CREAM

LULICONAZOLE
$7.9476per GM

Strength

10 mg/g

Manufacturer

Bausch Health US LLC

NDC

99207085060

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Last Updated

1/5/2018

Active Ingredients

LULICONAZOLE

Approval Type

New Drug (NDA)

FDA Application

NDA204153

On Market Since

11/14/2013

Pharmacological Classes

Azole Antifungal
Azoles
Cytochrome P450 2C19 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+29.2%

Generic Alternatives

Save up to 66%

1 alternative • Same active ingredient

LULICONAZOLE 1% CREAM
Generic
68682085060•Oceanside Pharmaceuticals
$2.6814
Save 66%

Related Drugs

Same classification

LOTRIMIN AF 2% POWDER
Brand
11523091901•Bayer HealthCare LLC
$0.0487
per GM
REMEDY ANTIFUNGAL 2% CREAM
Brand
53329016204•Medline Industries, LP
$0.0489
per ML
MICRO-GUARD 2% POWDER
Brand
11701003816•Coloplast Manufacturing US, LLC
$0.0573
per GM
VANDAZOLE VAGINAL 0.75% GEL
Brand
00245086070•Upsher-Smith Laboratories LLC
$0.3451
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096301•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096307•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096305•Bayer HealthCare LLC
$0.5097
per GM
FUNGOID 2% TINCTURE
Brand
00884029301•Pedinol Pharmacal, Inc.
$0.5848
per ML
NEXIUM 24HR 22.3 MG CAPSULE
Brand
00573245014•Haleon US Holdings LLC
$0.5906
per EA
NEXIUM 24HR 22.3 MG CAPSULE
Brand
00573245028•Haleon US Holdings LLC
$0.5906
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy